ArticleArchivum immunologiae et therapiae experimentalis2016

HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of Riboflavin.

Agnieszka Irena Mazur-Bialy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.